Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the ...
Onlymyhealth on MSN
Period Party Powered By Sirona: Experts Break One Taboo At A Time In The Ask Me Anything Segment
OnlyMyHealth and HerZindagi by Jagran New Media’s initiative Period Party 30 – School Edition powered by Sirona attempted to ...
FDA approves Agios' Aqvesme for anemia in alpha and beta thalassemia, backed by Phase 3 data and a REMS safety program.
Stripe patterns are commonly seen in nature – for instance birds and fish move in coordinated flocks and schools, fingerprints form unique designs ...
Here is the full list of the health and wellness Startup Battlefield 200 selectees, along with a note on what made us select ...
Shares of Agios Pharmaceuticals jumped nearly 12% premarket on Wednesday after the U.S. Food and Drug Administration ...
Study Finds on MSN
Are Vegan Children Healthier? Massive Study Reveals Which Nutrients Plant-Based Kids Are Most Likely To Miss
Massive review finds vegetarian and vegan kids are leaner with better cholesterol, but face significantly higher vitamin and ...
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or ...
Feeling cold all the time isn’t just weather-related. Research links it to anemia, thyroid issues, slow metabolism, and ...
Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...
Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.
Agios Pharmaceuticals shares surged after the FDA approved expanded use of its drug mitapivat for treating anemia in alpha- and beta-thalassemia patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback